POLE2
Basic information
Region (hg38): 14:49643555-49688422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLE2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 49 | ||||
missense | 141 | 148 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 12 | 12 | ||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 11 | 23 | 2 | 36 | ||
non coding | 59 | 70 | ||||
Total | 0 | 0 | 169 | 99 | 19 |
Variants in POLE2
This is a list of pathogenic ClinVar variants found in the POLE2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-49643647-G-A | POLE2-related disorder | Benign (Sep 26, 2019) | ||
14-49643672-TG-T | Uncertain significance (Jun 16, 2022) | |||
14-49643674-A-T | Likely benign (Jun 16, 2022) | |||
14-49643675-A-T | Uncertain significance (Jun 16, 2022) | |||
14-49643680-G-GA | Benign (Nov 30, 2024) | |||
14-49643690-T-A | Likely benign (Nov 06, 2024) | |||
14-49647273-G-A | Likely benign (Dec 15, 2022) | |||
14-49647273-G-C | Likely benign (Dec 09, 2023) | |||
14-49647279-G-A | Likely benign (Aug 02, 2023) | |||
14-49647283-A-G | Likely benign (Jun 13, 2024) | |||
14-49647295-A-G | Likely benign (Nov 29, 2024) | |||
14-49647302-A-G | Likely benign (Oct 30, 2024) | |||
14-49647305-G-A | Uncertain significance (Mar 15, 2024) | |||
14-49647307-C-G | Uncertain significance (Oct 26, 2023) | |||
14-49647316-A-T | Likely benign (Mar 24, 2022) | |||
14-49647318-G-A | not specified | Uncertain significance (Aug 15, 2024) | ||
14-49647325-A-C | Benign (Aug 13, 2024) | |||
14-49647327-CTT-C | Uncertain significance (Oct 28, 2024) | |||
14-49647339-A-G | Uncertain significance (Sep 03, 2024) | |||
14-49647340-TC-T | Uncertain significance (Jan 11, 2024) | |||
14-49647350-G-A | Uncertain significance (Oct 09, 2024) | |||
14-49647356-G-C | not specified | Uncertain significance (Aug 04, 2023) | ||
14-49647358-G-A | Likely benign (May 22, 2024) | |||
14-49647359-C-T | Uncertain significance (Mar 19, 2022) | |||
14-49647363-T-C | Uncertain significance (Mar 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLE2 | protein_coding | protein_coding | ENST00000216367 | 19 | 44868 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.85e-7 | 0.996 | 125678 | 0 | 66 | 125744 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.791 | 232 | 268 | 0.864 | 0.0000136 | 3432 |
Missense in Polyphen | 56 | 76.44 | 0.7326 | 1017 | ||
Synonymous | 0.0667 | 89 | 89.8 | 0.991 | 0.00000446 | 957 |
Loss of Function | 2.60 | 16 | 31.8 | 0.503 | 0.00000163 | 408 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000412 | 0.000396 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000170 | 0.000163 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000421 | 0.000413 |
Middle Eastern | 0.000170 | 0.000163 |
South Asian | 0.0000691 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in DNA repair and in chromosomal DNA replication.;
- Pathway
- Nucleotide excision repair - Homo sapiens (human);Pyrimidine metabolism - Homo sapiens (human);Base excision repair - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);DNA replication - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Retinoblastoma (RB) in Cancer;Pyrimidine metabolism;G1 to S cell cycle control;DNA Replication;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;Homology Directed Repair;Purine metabolism;Activation of the pre-replicative complex;Mitotic G1-G1/S phases;DNA replication initiation;DNA Replication;Pyrimidine metabolism;Synthesis of DNA;S Phase;PCNA-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Resolution of Abasic Sites (AP sites);Base Excision Repair;Telomere C-strand synthesis initiation;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Telomere Maintenance;Chromosome Maintenance;G1/S Transition;Recognition of DNA damage by PCNA-containing replication complex;DNA Replication Pre-Initiation;M/G1 Transition;Termination of translesion DNA synthesis;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass;Cell Cycle;Dual Incision in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Cell Cycle, Mitotic;Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.0896
Intolerance Scores
- loftool
- 0.830
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Haploinsufficiency Scores
- pHI
- 0.962
- hipred
- Y
- hipred_score
- 0.590
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.703
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pole2
- Phenotype
Zebrafish Information Network
- Gene name
- pole2
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- necrotic
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA-dependent DNA replication;DNA repair;error-prone translesion synthesis
- Cellular component
- nucleoplasm;epsilon DNA polymerase complex;nuclear body;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;protein binding